sorafeniblenvatinibnivolumabipilimumabNIVOSORIPILEN
… trial assessing nivolumab plus ipilimumab versus lenvatinib or sorafenib for unresectable hepatocellular carcinoma in the first-line set…
1articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: LEN ×
LEN
This drug is selected. Its supporting articles are shown below.